Article

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: Statistical Analysis Plan

2020-04-20

Abstract excerpt

<h4>Background</h4> The Melanoma Genomics Managing Your Risk Study is a randomised controlled trial that aims to evaluate the efficacy of providing information on personal genomic risk of melanoma in reducing ultraviolet radiation (UV) exposure, stratified by traditional risk group (low or high phenotypic risk) in the general population. The primary outcome is objectively measured total daily Standard Erythemal Do...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f5577a40-976e-5a6d-b62b-cfccefae3707
DOI: 10.1101/2020.04.13.20064246

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: Statistical Analysis PlanDOI 10.1101/2020.04.13.20064246Read

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.Semantic proximity Read

The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.Semantic proximity Read

Recommendations for Primary Prevention of Skin MelanomaSemantic proximity Read

A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.Semantic proximity Read

Exploring the Potential Emotional and Behavioural Impact of Providing Personalised Genomic Risk Information to the Public: A Focus Group Study.Semantic proximity Read

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.Semantic proximity Read

A genetically informed study reveals modifiable pathways in skin cancer.Semantic proximity Read

Can Patient-Led Surveillance Detect Subsequent New Primary or Recurrent Melanomas and Reduce the Need for Routinely Scheduled Follow Up? A Protocol for the MEL-SELF Randomised Controlled Trial.Semantic proximity Read

Development and Evaluation of a Telephone Communication Protocol for the Delivery of Personalized Melanoma Genomic Risk to the General PopulationSemantic proximity Read

Evaluating an approach for communicating integrated risk scores for melanoma.Semantic proximity Read

GP attitudes to and expectations for providing personal genomic risk information to the public: a qualitative studySemantic proximity Read

The Queensland Study of Melanoma: environmental and genetic associations (Q-MEGA); study design, baseline characteristics, and repeatability of phenotype and sun exposure measures.Semantic proximity Read